Abstract
Heart transplantation is the treatment of choice for refractory heart failure, despite the great improvement in life expectancy with clinical treatment. The prevention of acute rejection still presents important challenges in diagnosis and therapy, with 20-40% of transplant patients having an episode of acute cellular rejection in the first year after transplantation. A cholesterol-rich (…